About: Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor"associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.54 (+0.21%)
ODTX NASDAQ Odyssey Therapeutics, Inc. Common Stock
Odyssey Therapeutics, Inc. Common Stock share price
ODTX price activity
Last Price
$19.540
Change (24hr)
0.04 USD (0.21%)
Volume
209.80K
Volume (4w avg)
-
Open
$19.33
Day Range
$19.19 - $20.07
Previous Close
$19.50
Last Trade
28 Oct, 8:28 pm GMT+0
Delayed
28 Oct, 8:28 pm GMT+0
ODTX price performance
Delayed
28 Oct, 8:28 pm GMT+0
ODTX Market Signals